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SummARy – The group of severe cutaneous drug reactions with systemic symptoms includes 
several syndromes: toxic epidermal necrolysis, Stevens-Johnson syndrome, acute generalized exant-
hematous pustulosis, and drug reaction with eosinophilia and systemic symptoms (DRESS). These 
reactions occur several days to six weeks after introducing the incriminating drug. The skin and 
internal organs (liver, kidneys, lungs, etc.) are usually involved. A great possibility of lethal outco-
me is a critical characteristic of these syndromes. A patient with pyelonephritis diagnosed during 
emergency room workup is described. Ciprofloxacin was prescribed and the patient was discharged. 
After ten days, the patient came back with worsening condition, general inflammatory response, 
skin changes, liver and kidney damage, and eosinophilia. DRESS syndrome was diagnosed based 
on clinical and other findings. The diagnosis and treatment of severe drug reactions with cutaneous 
and systemic symptoms pose a medical challenge. 
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Introduction 
Severe forms of cutaneous drug reactions associat-
ed with systemic symptoms are one of the biggest di-
agnostic and treatment challenges in allergology. Such 
reactions usually start several days to six weeks after 
drug introduction. They occur in the form of changes 
on the skin and internal organs (liver, kidneys, lungs, 
etc.). Among severe cutaneous drug reactions with 
systemic symptoms, toxic epidermal necrolysis (tEn) 
is emphasized because of the highest mortality rate 
(30%-35%). There also are Stevens-Johnson syndrome 
(SJS) and transitional forms, all similar to tEn, but 
less extensively affecting the skin and thus having 
lower mortality (5%-15%). on the other hand, reac-
tion called drug reaction with eosinophilia and sys-
temic symptoms (DRESS), which is a form of hyper-
sensitivity syndrome, has a mortality of about 10%1. 
one more syndrome should also be mentioned, i.e. 
acute generalized exanthematous pustulosis (AgEp) 
caused by medication. unless properly treated, it is as-
sociated with a mortality of up to 5%. AgEp is char-
acterized specifically by hundreds or even thousands 
of sterile, non-follicular pustules2,3.
The SJS-tEn is usually induced by a medication. 
nevertheless, other etiologies should also be taken 
into consideration, e.g., graft versus host disease. 
There are reports on several cases of SJS-tEn associ-
ation with infections (Mycoplasma pneumoniae), while 
in some cases the etiology remained unexplained1. 
The SJS-tEn is most commonly associated with the 
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usage of certain drugs, e.g., sulfonamides, anticon-
vulsants, some nonsteroidal anti-inflammatory drugs 
(nSAiDs) and allopurinol1. Rarely, SJS-tEn is de-
scribed as a consequence of antiresorptive therapy, 
particularly alendronate. Also, there is a significantly 
increased risk for the development of this syndrome 
in hiV infection and autoimmune diseases (e.g., sys-
temic lupus erythematosus)1,4.
when it comes to AgEp and the incriminat-
ing drugs, the main cause of AgEp are antibiotics, 
in particular beta-lactams and macrolides; however, 
other etiologies are possible, such as viruses (b19 and 
enterovirus), mercury, bite of a spider, or other medi-
cations3.
DRESS syndrome is also known as a drug induced 
hypersensitivity syndrome (DihS). generally, it is a 
reaction to the medication. DRESS is clinically de-
fined by a triad of symptoms including fever, skin rash, 
and internal organ involvement that can be symptom-
atic or asymptomatic. The most common organs in-
volved are the liver, kidneys and lungs5. Eosinophilia 
(≥1500/ml) is an obligatory laboratory finding in 
DRESS syndrome6. leukocytosis and lymphocytosis 
are also common5. 
Such reactions to drugs are known for a long time. 
for instance, the anticonvulsant hypersensitivity syn-
drome (AhS) was first described in 1950 by Chaiken 
et al.7. in 1996, bocquel et al. proposed the acronym 
DRESS for drug reaction with eosinophilia and sys-
temic symptoms, a syndrome that unites numerous 
syndromes, also drug reactions with common char-
acteristics: AhS, dapsone syndrome, etc.5,8. There-
fore, DRESS syndrome is nowadays a frequently used 
term.
The incidence of DRESS syndrome remains un-
clear. because of the variable presentation along with 
various clinical and laboratory findings, proper rec-
ognition of the syndrome is very difficult and routine 
term utilization is not possible without uniformly ac-
cepted criteria. 
As in SJS-tEn, in DRESS syndrome cutane-
ous lesions and systemic disorders occur due to the 
drug taken. DRESS is most often associated with 
anticonvulsants, sulfonamides, dapsone, allopurinol, 
minocycline and gold salts1,9,10. Some publications de-
scribe rare occurrence of this syndrome as a response 
to nSAiDs, quinolones, and antiresorptive drugs 
(strontium ranelate)11-13.
The pathophysiology of DRESS and SJS-tEn 
is similar. it is a drug-induced immune reaction, an 
allergic hypersensitivity reaction type iV. Some au-
thors consider the possibility of enzyme defects (slow 
acetylators) in the metabolism14. full complexity of 
the immunopathogenesis in DRESS syndrome is best 
illustrated through a two-way relationship with au-
toimmune diseases. Autoimmunity increases the risk 
of DRESS syndrome, while DRESS can lead to the 
occurrence of autoimmune reaction15,16. A common 
factor for this bilateral connection could be viral coin-
fection (especially herpesvirus reactivation, hhV6, 
EbV)17-19.
inflammatory response in patients with DRESS 
usually begins with high or low fever. The patient de-
velops maculopapular skin rash, lymphadenitis and 
pharyngitis in the next day or two19,20. Then there 
are organosystemic manifestations, most commonly 
hepatitis, eosinophilia, blood dyscrasias and nephritis. 
The presence of three of these criteria is sufficient to 
diagnose DRESS syndrome. other possible findings 
in DRESS patients include pneumonitis, hepatosple-
nomegaly, oral ulcers, exudative tonsillitis, strawberry 
tongue, periorbital or facial edema, myopathy, flu-like 
symptoms, disseminated intravascular coagulopathy, 
colitis, and hypothyroidism5.
Although the diagnosis can be set by lymphocyte 
transformation test and patch test, DRESS is mainly 
diagnosed by the time of onset (the time elapsed from 
taking the medication to the occurrence of disease), 
clinical examination, laboratory tests, and recovery 
after the culprit drug discontinuation5. Sometimes 
additional diagnostic tests may be required.
when DRESS is timely and appropriately treated, 
organ damage can usually be reversed and the func-
tion of affected organs fully restored. for example, 
acute interstitial nephritis will spontaneously regress 
within weeks, if the precipitating agent is removed21.
Early diagnosis, etiology determination and im-
mediate discontinuation of suspect drug are most im-
portant in therapeutic process. Development of this 
type of allergic reactions to drugs should be suspected 
at the first glance to skin or mucosa changes, mostly 
associated with the use of anticonvulsants, sulfon-
amides, allopurinol, or (in rheumatology) nSAiDs 
and very rarely antiresorptive therapy. in therapeutic 
terms, it is crucial to stop the responsible medica-
tion. in general, treatment of these allergic reactions 
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to drugs is symptomatic. in severe cases, treatment is 
carried out in intensive care units, according to the 
principles of skin burn management: warm environ-
ment, electrolyte disbalance correction, parenteral 
hyperalimentation and prevention of sepsis1. it is dif-
ficult to assess the efficacy of drugs described in some 
case reports: intravenous immunoglobulin (iVig), 
cyclosporine, cyclophosphamide, pentoxifylline, and 
thalidomide. Questionable is the use of corticoster-
oids in severe forms of tEn. in DRESS syndrome, 
corticosteroids may be useful to manage damage to 
internal organs (hepatitis, nephritis, pneumonitis)1. 
The use of the mentioned treatment measures is as-
sociated with mortality reduction and faster re-epi-
thelialization of skin lesions. 
in the future, the patient should completely avoid 
usage of the incriminating drug, even in allergic test-
ing. 
Case Report
A female patient aged 57 presented to internal 
emergency clinic for the left lumbar pain. Clinically, 
she had fever, chills, shivering and dysuria. laboratory 
findings and abdominal ultrasonography verified the 
clinical diagnosis of acute left-side pyelonephritis with 
ipsilateral nephrolithiasis. urine microbiology showed 
Enterococcus faecalis. The patient was discharged with 
recommendation for ciprofloxacin therapy for 10 days, 
abundant rehydration, diclofenac and paracetamol as 
needed. 
After 10 days of the introduction of ciprofloxacin, 
the patient presented for follow up with worsening of 
general symptoms despite regression of dysuric prob-
lems. new signs appeared including feeling of weight 
in the muscles, itching, and mild exanthema mainly 
on the trunk skin and upper extremities, without 
mucosal ulceration. The patient was still subfebrile. 
laboratory findings showed an increase in leukocyte 
count (l 28x109/l), primarily on the account of eo-
sinophilia (Eo 17.80x109/l, 63.5%) (fig. 1), and in 
liver enzymes (ASt 71.5 iu/l, Alt 104.4 iu/l, Ap 
321 iu/l, ggt 119 iu/l) (fig. 2); protein immuno-
electrophoresis yielded elevated levels of igE (368 iu/
ml). leukocyturia and erithrocyturia persisted, with 
60% of dysmorphic and 40% of smooth red blood 
cells. Escherichia coli was isolated from urine. 
These findings brought into question the efficacy of 
current therapy. Changes were indicative of possible 
medication side effects, i.e. ciprofloxacin as a newly 
introduced drug still used. Therefore, ciprofloxacin 
was removed from therapy. Amoxicillin with clavu-
lanic acid and mebendazole were introduced instead 
of ciprofloxacin. There was a decrease in eosinophil 
count (Eo 12.70x109/l, 57.6%) two days after cipro-
floxacin discontinuation. Shortly after, the itch and 
skin rash spontaneously regressed, and the patient’s 
general condition improved. in the next two months, 
eosinophil count and liver enzyme levels gradually de-
creased until final follow up values of Eo 1.11x109/l 
(14.9%) (fig. 1), ASt 17 iu/l, Alt 25.8 iu/l, Ap 
107 iu/l, and ggt 37 iu/l (fig. 2). There were 
100% of dysmorphic erythrocytes in the urine. Re-
peat abdominal ultrasonography showed a wider 
prominent pyramid in the left kidney, meaning that 
the inflammation led to permanent damage. 
Fig. 1. Trends in the number of eosinophils in circulating blood. Fig. 2. Changes in the levels of liver enzymes.
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Additional serology did not confirm the presence 
of viral or parasitic infection agents. Analysis of pe-
ripheral blood smear yielded normal findings, except 
for the still present mild eosinophilia, which was on 
a decline. According to mSCt of the abdomen and 
values of tumor markers that were within the nor-
mal limits, tumor etiology of eosinophilia was ruled 
out. Additional studies for autoimmune etiology have 
been planned. 
The clinical symptoms in our patient regressed 
short after discontinuation of the culprit drug, so she 
did not require differential treatment. laboratory 
findings normalized short after drug discontinuation, 
only kidney function recovered gradually, over several 
weeks. The patient has been referred for regular fol-
low up of liver and kidney function, with additional 
diagnostic workup that will rule out the possible dis-
ease of other target organs. She was advised to avoid 
using ciprofloxacin for either diagnostic or therapeutic 
purpose in the future. A year after the occurrence of 
DRESS syndrome, the patient was free from recur-
rence. 
Discussion 
Regarding the severe systemic drug reactions with 
skin manifestations, one should always bear in mind 
the possibility of reaction to the medication the patient 
has been taken; therefore, adequate information on it 
should be taken from the patient. Sometimes it is dif-
ficult to distinguish types of drug reactions, especially 
when there is an overlap of symptoms. in DRESS, 
the most important laboratory finding is eosinophilia, 
which distinguishes it from other severe systemic drug 
reactions with skin manifestations22. besides DRESS, 
another possible manifestation of drug reaction is SJS/
tEn, characterized by the presence of blisters (SJS 
<10% and tEn >30% of total body surface area). in 
most of these patients, the lining of the mouth, con-
junctiva, and genitals is affected. tEn also affects 
areas on the inner epithelium surfaces (lung, gastro-
intestinal tract), and multiple organ failure may occur, 
as in DRESS. tEn and DRESS may occasionally 
have similar clinical presentation. our patient had a 
mild skin reaction, differentially presented in many 
diseases and syndromes. Although the clinical picture 
of her skin changes seemed insignificant, after col-
lecting additional history data on the occurrence and 
diagnostic analysis, DRESS was suspected and subse-
quently confirmed. timely elimination of ciprofloxa-
cin prevented progression of the disease. The lesions 
regressed spontaneously, confirming the diagnosis. 
Such mild forms of DRESS syndrome have already 
been reported in the literature20. however, the mild 
form of skin reactions should not mislead us. involve-
ment of the kidneys and liver, together with signifi-
cant eosinophilia, were crucial in establishing the cor-
rect diagnosis in our patient. Considerable difficulties 
encountered on setting up the diagnosis impose the 
question of the actual prevalence of the disease.
in terms of pathophysiology, this reaction with 
maculopapular exanthema and eosinophilia in DRESS 
is hypersensitivity reaction type iV, i.e. the mecha-
nism of cellular immunity22. Thereby, development of 
DRESS includes Th2-lymphocytes and CD8+ cells20. 
it is likely that Th2 cells induce type iVb hypersensi-
tivity response affecting the skin, while CD8+ t cells 
cause damage to internal organs23. 
Study results have shown the mortality of DRESS 
syndrome to be 10%22. it should be noted that liver in-
volvement is a poor prognostic sign, and together with 
icteric pruritus predicts the possible fatal outcome in 
20% of patients20. Early elimination of the causal drug 
results in better patient prognosis. unfortunately, the 
factors that determine the severity of organ failure 
or the number of affected organs remain unknown, 
although the potential role of genetic factors is con-
sidered. Therefore, according to some authors, close 
patient relatives should avoid the same drug too22.
Some authors believe that systemic corticosteroid 
therapy is required in DRESS syndrome1. The rec-
ommended dose is prednisolone 40-60 mg/day for 
at least 6-8 weeks to avoid symptom relapse. in our 
patient, we did not use systemic steroids, but only 
supportive therapy, rehydration, given that changes 
gradually regressed spontaneously. however, no ran-
domized placebo-controlled study supports or rejects 
this opinion20,22. Several cases have been described of 
patients with DRESS and extensive internal organ 
involvement, such as fulminant hepatitis, responding 
favorably to systemic corticosteroids24. taking into ac-
count the respective therapy side effects (particularly 
infection and sepsis), we believe that systemic corti-
costeroids are justified in severe forms of DRESS. 
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literature reports on the management of DRESS 
patients indicate successful treatment with intravenous 
pulsed dose of methylprednisolone (30 mg/kg for 3 
days), iVig, plasmapheresis, or combinations of these 
therapies20. it is considered that the use of iVig is 
indicated in fulminant forms of DRESS syndrome. 
According to the possible viral etiopathogenesis of 
DRESS, future studies should perhaps take into ac-
count the antiviral agents like ganciclovir as the pos-
sible prevention or treatment agent19. 
mild forms of DRESS, as in our patient, in gen-
eral recover spontaneously within weeks without the 
use of systemic corticosteroids. however, such cases 
require regular follow up of liver and kidney function, 
along with additional tests to exclude damage to other 
target organs, e.g., lungs, heart and thyroid gland. 
Due attention should be paid to the thyroid gland 
function because hypothyroidism may occur several 
months after recovery from the acute illness20.
Conclusion 
The occurrence of itch and rashes in patients tak-
ing drug therapy should not be simply considered as 
transient and benign changes. A more comprehensive 
analysis is proposed including liver and kidney func-
tion studies because the underlying disorder may be a 
systemic, severe cutaneous reaction to a drug, such as 
DRESS. Early diagnosis, identification of the etiol-
ogy and therapy, starting with early discontinuation of 
the suspected drug, are most important in therapeutic 
process. for now, only elimination of the drug has a 
definitely proven therapeutic effect, therefore, early 
diagnosis is the key factor. This report may hopefully 
upgrade the awareness of this rare syndrome. 
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Sažetak
SinDRom DRESS S blAgim mAnifEStACiJAmA KAo DiJAgnoStičKi i tERApiJSKi pRoblEm: 
pRiKAZ SlučAJA
M. Artuković, J. Kuštelega i L. Lugović-Mihić 
teške oblike kožnih reakcija na lijekove povezanih sa sistemskim simptomima čini nekoliko sindroma: toksična epi-
dermalna nekroliza, Stevens-Johnsonov sindrom, akutna generalizirana egzantematozna pustuloza te reakcija na lijekove s 
eozinofilijom i sistemskom reakcijom (DRESS). Kod takvih reakcija se nekoliko dana do 6 tjedana od uvođenja lijeka po-
jave promjene na koži, a često su zahvaćeni i unutarnji organi (jetra, bubrezi, pluća i dr.). Zbog toga je u ovakvim oblicima 
preosjetljivosti na lijekove velika smrtnost. opisuje se slučaj bolesnice kojoj je ambulantno dijagnosticiran pijelonefritis, 
te je bila otpuštena kući uz preporuku terapije ciprofloksacinom. Deset dana kasnije bolesnica se vratila u ambulantu s 
pogoršanjem kliničke slike, lošeg općeg stanja, uz pojavu kožnih eflorescencija, oštećenje jetrene i bubrežne funkcije te s 
eozinofilijom. na temelju kliničkih nalaza i ostale obrade postavljena je dijagnoza sindroma DRESS. Dijagnoza i terapija 
teških oblika reakcija na lijekove i u današnje vrijeme predstavljaju medicinski izazov.
Ključne riječi: Preosjetljivost na lijekove – prevencija i kontrola; Erupcije uzrokovane lijekovima – etiologija; Erupcije uzro-
kovane lijekovima – dijagnostika; Erupcije uzrokovane lijekovima - terapija
